Oct 3, 2008· American Chemistry Council (GBL/BDO Panel) - Comment· FDA-2008-N-0448-0004
Please find attached comments submitted by the American Chemistry Council GBL/BDO Panel in regard to FDA Docket Number 2008-N-0448.
FDANonrulemakingFDA-2008-N-0448
International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Gamma-hydroxybutyric acid (GHB); Ketamine; Dextromethorphan; N-benzylpiperazine (BZP); 1-(3-trifluoromethylphenyl)piperazine (TFMPP); 1-(3-chlorophenyl)piperazine (mCPP); 1-(4-Methoxyphenyl)piperazine (MeOPP); 1-(3,4-methylenedioxybenzyl)piperazine (MDBP); Gamma-butyrolactone; 1,4-Butanediol
RIN
—
Last modified
Jan 5, 2022
Comment window
closed 4901d ago
American Chemistry Council filings
1
Activity
American Chemistry Council filed 1 comment on this docket between Oct 3, 2008 and Oct 3, 2008. 2 other organizations filed here. The comment window closed 4901d ago.
What American Chemistry Council filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (2)
See everyone who commented →- American Chemistry CouncilTHIS ORG1 filing · confidence 97%
- Consumer Healthcare Products Associationtrade assoc.1 filing · confidence 97%
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%